Miano_edit_Layout 1 23/09/2009 13:03 Page 19
Treatment of Benign Prostatic Hyperplasia in the Geriatric Patient
1. Fried LP, Tangen CM, Waltson J, et al.; J Gerontol A Biol Sci 22. Landi F, Russo A, Liperoti R, et al., Clin Pharmacol Ther, 42. Hill B, Belville W, Bruskewitz R, et al., J Urol,
Med Sci, 2001;56:M146–156. 2007;81:235–41. 2004;171:2336–40.
2. Council on Scientific Affairs, Arch Intern Med, 23. Lepor H, Williford WO, Barry MJ, et al., N Engl J Med, 43. Boyle P, Roberston C, Vaughan ED, Fitzpatrick JM, BJU Int,
1990;150:2459–72. 1996;335:533–9. 2004;94:83–8.
3. Jacobsen SJ, Girman CJ, Lieber MM, Urology, 2001;58 24. Debruyne FMJ, Jardin A, Colloi D, et al., Eur Urol, 44. Tubaro A, Hofner K, Villavicencio H, et al., Eur Urol Suppl,
(6 Suppl. 1):5–16. 1998;34:169–75. 2006;5(2):274, abstract 1006.
4. Meigs JB, Barry MJ, Giovannucci E, et al., J Urol, 25. Kirby RS, Roherborn C, Boyle P, et al., Urology, 45. Tan AH, Gilling PJ, Kennett KM, et al., J Urol,
1999;162:376–82. 2003;61:119–26. 2003;170:1270–74.
5. McConnell JD, Roehrborn CG, Baustita OM, et al., N Engl J 26. Boyle P, Gould AL, Roherborn CG, Urology, 46. Tooher R, Sutherland P, Costello A, et al., J Urol,
Med, 2003;349:2387–98. 1996;48:398–405. 2004;171:1773-81
6. McConnell JD, Bruskewitz R, Walsh P, et al., N Engl J Med, 27. Roherborn CG, Boyle P, Nickel JC, et al., Urology, 47. Tan AH, Gilling PJ, Curr Opin Urol, 2005;15:55–8.
1998;338:557–63. 2002;60:434–41. 48. Seki N, Mochida O, Kinukawa N, et al., J Urol,
7. AUA Practice Guidelines Committee, J Urol, 28. Harrison RH III, Boren JS, Robinson JR, J Urol, 2003;170:1847–50.
2003;170:530–47. 1956;75:95–110. 49. Kuntz RM, Lehrich K, Ahyai SA, Eur Urol,
8. Chatelain C, Denis L, Foo JKT, et al. In: Benign Prostatic 29. Ho HS, Yip SK, Lim KB, et al., Eur Urol, 2007;52(2):517–22. 2008;53(1):160–66.
Hyperplasia, 5th International Consultation on Benign Prostatic 30. Singh H, Desai MR, Shrivastav P, Vani K, J Endourol, 50. Ahyai SA, Lehrich K, Kuntz RM, Eur Urol, 2007;52:1456–64.
Hyperplasia (BPH), June 25–28, 2000, Paris, Plymouth: 2005;19(3):333–8. 51. Naspro R, Bachmann A, Gilling P, et al., Eur Urol,
Plymbridge Distributors Ltd, 2001;519–34. 31. de Sio M, Autorino R, Quarto G, et al., Urology, 2009;55:1345–57.
9. Steers WD, AUA News, 2007;12(4):15–16. 2006;67(1):69–72. 52. Malek RS, Kuntzman RS, Barret DM, J Urol,
10. Turnheim K, Exp Gerontol, 2003;38:843–53. 32. Starkman JS, Santucci RA, BJU Int, 2005;95(1):69–71. 2000;163:1730–33.
11. Shapiro E, Hartanto V, Lepor H, Prostate, 1992;21:297–307. 33. de la Rosette JJ, Francisca EA, Kortmann BB, BJU Int, 53. Malek RS, Kuntzman RS, Barret DM, J Urol,
12. Djavan B, Eur Urol Suppl, 2004;3:23–30. 2000;86:47–51. 2005;174:1344–8.
13. Lowe F, Narayan P, Djavan B, Eur Urol Suppl, 2002;1(1):108, 34. de Wildt MJ, Debruyne FM, de la Rosette JJ, Urology, 54. Bachmann A, Schurch L, Ruszat R, et al., Eur Urol,
abstract 42. 1996;48:416–23. 2005;48:965–71.
14. Buzelin JM, Fonteyne E, Kontturi M, et al., Br J Urol, 35. Thalmann GN, Mattei A, Treuthardt C, et al., J Urol, 55. Van Cleynenbreugel B, Srirangam SJ, Van Poppel H, Curr
1997;80:597–605. 2002;167:2496–2501. Opin Urol, 2009;19:33–7.
15. Lowe FC, Clin Ther, 1997;19:730–42. 36. d’Ancona FC, Francisca EA, Debruyne FM, de la Rosette 56. Ogiste JS, Cooper K, Kaplan SA, Curr Opin Urol,
16. Chapple C, Baert L, Thind P, et al., Eur Urol, JJ, J Endourol, 1997;11:285–9. 2003;13:51–7.
1997;32:462–70. 37. Vesely S, Knutson T, Dicuio M, et al., J Endourol, 57. Barber NJ, Roodhouse AJ, Rathenborg P, et al., BJU Int,
17. van Kerrebroeck P, Jardin A, van Cangh P, Laval KU, Eur 2005;19(6):730–33. 2005;96:578–80.
Urol, 2002;41:54–61. 38. Wagrell L, Schelin S, Nordling J, et al., Urology, 58. Corica AP, Larson BT, Sagaz A, et al., BJU Int,
18. Abdel-Aziz S, Mamalis N, Curr Opin Ophtalmol, 2004;64(4):698–702. 2004;93:346–8.
2009;20(1):37–41. 39. Mattiasson A, Schelin S, Magnusson B, et al., Urology, 59. Madersbacher S, Eur Urol, 2006;49:212–14.
19. Artibani W, Eur Urol Suppl, 2004;3:1–6. 2007;69(1):91–6. 60. Dineen MK, Shore ND, Lumerman JH, et al., Urology,
20. Kaplan SA, Roherborn GC, Rovner SE, et al., JAMA, 40. Schelin S, Eur Urol, 2001;39:400–404. 2008;71(5):873–7.
2006;296:2319–28. 41. Hoffman RM, Monga M, Elliot SP, et al., Cochrane Database
21. Ancelin ML, Artero S, Portet F, et al., BMJ, 2006;332:455–9. Syst Rev, 2007;(4):CD004135.
Performed by More Urologists
Worldwide
Have you seen the light?
Documented clinical outcomes equivalent to TURP with fewer complications…
Proven safe and effective in more than 375 clinical articles and abstracts…
532nm wavelength influencing procedural efficiency and patient outcomes.
It’s no wonder GreenLight is used by more urologists than
any other laser for the treatment of BPH.
Come see the light at
www.GreenLightHPS.com
See the Instructions for Use and the Operator’s Manual for the complete directions,
contraindications, warnings and risks associated with the device.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92